A 60-year-old lady with mild fever, blood tinged sputum, and a left upper lung mass had whole body F-18 2-deoxy-D-glucose (FDG) positron emission tomography (PET)-computer tomography (CT) for cancer staging. The PET-CT imaging revealed FDG accumulation in the left upper lung lesion. The histopathology of the left upper lobe lung resection showed a parasite tunnel with necrosis, parasite ova, and foreign body giant cells. After surgery, eosinophiles in the peripheral blood dropped from 20% of white cell counts before operation to 5.5% at 7 weeks postoperation.
A 71-year-old man with rectal cancer history was referred for FDG PET/CT due to serum carcinoembryonic antigen level elevation. In addition to rectal cancer recurrent lesion, the FDG PET/CT scan also showed homogeneous intense FDG accumulation in the whole segment of descending colon and a small air bubble in the urinary bladder. After furosemide injection, the vesicocolic fistula was confirmed by typical air pattern in the urinary bladder on attenuation CT images and the decrease FDG activity in the descending colon. The patient has had the clinical manifestations of pneumaturia and watery diarrhea which support the diagnosis of vesicocolic fistula.
A 59-year-old woman with recurrent cervical cancer and end-stage renal disease was referred for FDG PET/CT for restaging. The patient had hemodialysis for 4 years and radiotherapy 3 years ago and 1 year ago. The PET/CT scan showed recurrent cervical cancer and intense FDG radioactivity in the urinary bladder, with a small air bubble in both the urinary bladder and the vagina. After supine positioning without voiding, the delayed images showed more air bubbles with less FDG activity in the urinary bladder. The vesicovaginorectal fistula was confirmed by surgery.
Background/Objectives: The duration of the response to radiotherapy-related treatment is a critical prognostic indicator for patients with nasopharyngeal carcinoma (NPC). Persistent tumor status, including residual tumor presence and early recurrence, is associated with poorer survival outcomes. To address this, we developed a prediction model to identify patients at a high risk of persistent tumor status prior to initiating treatment. Methods: This retrospective study included 104 patients with NPC receiving radiotherapy-related treatment who had completed a 3-year follow-up period; 29 were classified into the persistent tumor status group and 75 into the disease-free group. Radiomic features were extracted from pretreatment positron emission tomography (PET) images and used to construct a prediction model by employing machine learning algorithms. The model’s diagnostic performance was assessed using the area under the receiver operating characteristic curve (AUC), whereas SHapley Additive exPlanations (SHAP) analysis was conducted to determine the contribution of individual features to the model. Results: The prediction model developed using the AdaBoost algorithm and validated through five-fold cross-validation achieved the highest AUC of 0.934. Its sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 89.66%, 86.67%, 72.22%, 95.59%, and 87.5%, respectively. SHAP analysis revealed that the feature of high dependence low metabolic uptake emphasis50 had the greatest impact on model predictions. Furthermore, patients classified as disease-free exhibited markedly higher overall survival rates compared with those with persistent tumor status. Conclusions: In conclusion, the proposed prediction model efficiently identified patients with NPC at a high risk of persistent tumor status by using radiomic features extracted from pretreatment PET images.
30 October 2009 in The Kaohsiung Journal of Medical Sciences
[2[[2‐[[[3‐(4‐chlorophenyl)‐8‐methyl‐8‐azabicyclo[3,2,1]‐oct‐2‐yl]‐methyl](2‐mercaptoethyl)amino]ethyl]amino]ethanethiolato(3‐)‐N2,N2′,S2,S2]oxo‐[1R‐exo‐exo)])‐[99mTc]‐technetium (99mTc‐TRODAT‐1) and 123I‐iodobenzamide (123I‐IBZM) are radiotracers for brain dopamine preand postsynaptic neuron imaging. The purpose of this study was to evaluate imaging parameters and crossed energy interference using simultaneous single photon emission computed tomography (SPECT) 99mTc and 123I data acquisition. A five‐compartment brain striatal phantom was filled with 99mTc and/or 123I radioactive solutions with different striatal‐to‐background ratios, ranging from 3:1 to 9:1. SPECT data were acquired with energy window settings of 15% for the centered window at 140 keV for 99mTc and a 10% asymmetric window at 159 keV for 123I. The experiments were carried out using either individual (99mTc or 123I only) or both radionuclides. The striatal‐to‐background ratios and energy crossed interference between 99mTc and 123I were calculated. The phantom SPECT images demonstrated that the energy crossed interferences from 123I to 99mTc, and vice versa, were 22 ± 12.4% and 0.4 ± 1.0%, respectively. A net interference of 7.1 ± 4.0% for the counts in the 15% centered 99mTc window can be expected from 123I and a net interference of 1.6 ± 3.3% for the counts in the 10% asymmetric 123I window was derived from 99mTc. The correlation of striatal‐to‐background ratios between single isotope and simultaneous dual‐isotope was excellent (R2 = 0.99). The imaging parameters used in this simultaneous dual‐isotope SPECT imaging could be used in future clinical practice for imaging patients with movement disorders by using 99mTc‐TRODAT‐1 and 123I‐IBZM. The striatal‐to‐background ratios were not affected by the crossed interference between 99mTc and 123I.